Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Faraday Future (NASDAQ: FFAI) Stock Climbs 3%. Here's Why?

Faraday Future Intelligent Electric Inc.(NASDAQ:FFIE)issued its weekly business update from Founder and Global Co-CEO YT Jia, outlining recent progress in financing, manufacturing, and market expansion initiatives.

Team Kalkine | 27 October 2025

LyondellBasell (NYSE:LYB) Receives “Hold” Consensus Rating from Analysts

LyondellBasell Industries N.V. (NYSE:LYB) has received an average rating of“Hold”from twenty analysts covering the stock, according to MarketBeat Ratings. Out of these, three analysts gave a“Sell”recommendation, thirteen issued a“Hold”, three rated it as a“Buy”, and one assigned a“Strong Buy.”

Aditi Sarkar | 27 October 2025

From UPS to Pfizer: Leading S&P 500 Stocks Fueling Reliable Dividend Payouts

Dividendincome accounts for nearly a third of totalS&P 500returns over the past century. While headline yields grab attention, long-term income growth relies on stable fundamentals and sustainable payouts, not merely high initial yields.

Team Kalkine | 27 October 2025

ChoiceOne Financial (NASDAQ:COFS) Posts Q3 Results After USD 1.8B Fentura Acquisition

ChoiceOne Financial Services, Inc.(NASDAQ:COFS), parent of ChoiceOne Bank, reported net income of USD 14,681,000 for the three months ended September 30, 2025, compared to USD 7,348,000 in the same period of 2024. For the nine months ended September 30, 2025, net income was USD …

Team Kalkine | 24 October 2025

Futures Rise Ahead of Key U.S. Inflation Data; Oil Gains, Gold Retreats, and Trade Tensions Dominate Headlines

Market Movers:On Thursday, the top gainers were Scienture Holdings, Inc. (+354.94%), followed by American Rebel Holdings, Inc. (+75.35%). On the contrary Agencia Comercial Spirits Ltd. (-33.72%), and Integer Holdings Corporation. (-32.28%) declined the most the same day.

Team Kalkine | 24 October 2025

Nanobiotix (NASDAQ:NBTX) Updates JNJ-1900 Phase 3 Clinical Program

Nanobiotix(NASDAQ:NBTX)reported updates on the JNJ-1900 clinical program following the transfer of NANORAY-312 Phase 3 trial sponsorship and operational control to Johnson & Johnson. The transfer, which began in 3Q2024, covers most regions and includes full operational oversight of the trial.

Team Kalkine | 24 October 2025

Alaska Air (NYSE:ALK) Announces Q3 Results and Global Route Expansion

Alaska Air Group(NYSE:ALK)posted GAAP net income of 73M USD, or 0.62 USD per share, which includes Hawaiian Airlines’ results. Adjusted net income, excluding special items and other adjustments, was 123M USD, or 1.05 USD per share. GAAP pretax margin reached 2.9%, while adjusted pretax …

Team Kalkine | 24 October 2025

X4 Pharmaceuticals (NASDAQ:XFOR) Prices USD 135M Public Offering to Advance Phase 3 Trial

X4 Pharmaceuticals(NASDAQ:XFOR)announced the pricing of its underwritten public offering of 45,860,000 shares of common stock at USD 2.90 per share. The company also issued pre-funded warrants allowing certain investors to purchase up to 700,000 shares at USD 2.899 per warrant. These warrants have an …

Team Kalkine | 24 October 2025

Faraday Future (NASDAQ:FFAI) Teams Up with RAK Motors for FX Super One UAE Rollout

Faraday Future Intelligent Electric Inc.(NASDAQ:FFIEW)announced a strategic collaboration with RAK Motors, a well-established automotive dealer based in Ras Al Khaimah, UAE. Through this partnership, RAK Motors will manage sales, delivery, and after-sales services for the FX Super One across the UAE.

Team Kalkine | 24 October 2025

Tesla (NASDAQ: TSLA) Forecasts Show Wide Split on AI, Robotics, and EV Growth

As of October 2025, Tesla (NASDAQ:TSLA) remains one of the most closely followed and debated U.S. equities. Analysts’ forecasts illustrate starkly different views, from ultra-bullish expectations rooted in Tesla’s AI and robotics potential to more conservative appraisals driven by margin pressures and intensifying EV …

Team Kalkine | 23 October 2025
Support

Hi! How can we help you today?

Loading…